SE9300300D0 - A novel anticoagulant entity, antibodies reacting specifically with the entity, and diagnostic and therapeutic used of the entity - Google Patents

A novel anticoagulant entity, antibodies reacting specifically with the entity, and diagnostic and therapeutic used of the entity

Info

Publication number
SE9300300D0
SE9300300D0 SE9300300A SE9300300A SE9300300D0 SE 9300300 D0 SE9300300 D0 SE 9300300D0 SE 9300300 A SE9300300 A SE 9300300A SE 9300300 A SE9300300 A SE 9300300A SE 9300300 D0 SE9300300 D0 SE 9300300D0
Authority
SE
Sweden
Prior art keywords
entity
diagnostic
reacting specifically
antibodies reacting
factor
Prior art date
Application number
SE9300300A
Other languages
English (en)
Inventor
Bjoern Dahlbaeck
Original Assignee
Bjoern Dahlbaeck
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bjoern Dahlbaeck filed Critical Bjoern Dahlbaeck
Priority to SE9300300A priority Critical patent/SE9300300D0/sv
Publication of SE9300300D0 publication Critical patent/SE9300300D0/sv
Priority to PCT/SE1994/000070 priority patent/WO1994017415A1/en
Priority to PL94310050A priority patent/PL181102B1/pl
Priority to BR9406223A priority patent/BR9406223A/pt
Priority to DE69411898T priority patent/DE69411898T3/de
Priority to CZ951849A priority patent/CZ184995A3/cs
Priority to US08/500,917 priority patent/US7169572B1/en
Priority to EP94905908A priority patent/EP0690991B2/en
Priority to HU9502190A priority patent/HUT72191A/hu
Priority to ES94905908T priority patent/ES2119165T5/es
Priority to AU59827/94A priority patent/AU690535B2/en
Priority to CA002154080A priority patent/CA2154080C/en
Priority to NZ261190A priority patent/NZ261190A/en
Priority to PL34254994A priority patent/PL181638B1/pl
Priority to DK94905908T priority patent/DK0690991T4/da
Priority to AT94905908T priority patent/ATE168781T1/de
Priority to JP6516938A priority patent/JPH08506181A/ja
Priority to FI953565A priority patent/FI953565A0/sv
Priority to GR980401874T priority patent/GR3027697T3/el
Priority to US11/560,502 priority patent/US20070212743A1/en

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SE9300300A 1993-01-29 1993-01-29 A novel anticoagulant entity, antibodies reacting specifically with the entity, and diagnostic and therapeutic used of the entity SE9300300D0 (sv)

Priority Applications (20)

Application Number Priority Date Filing Date Title
SE9300300A SE9300300D0 (sv) 1993-01-29 1993-01-29 A novel anticoagulant entity, antibodies reacting specifically with the entity, and diagnostic and therapeutic used of the entity
JP6516938A JPH08506181A (ja) 1993-01-29 1994-01-28 新規抗凝固性補助因子活性
HU9502190A HUT72191A (en) 1993-01-29 1994-01-28 Novel anticoagulant cofactor activity
AU59827/94A AU690535B2 (en) 1993-01-29 1994-01-28 Novel anticoagulant cofactor activity
BR9406223A BR9406223A (pt) 1993-01-29 1994-01-28 Método para determinar em uma amostra a atividade funcional de um componente da coagulação sanguinea método para diagnosticar um disturbio da coagulação/anticoagulação sanguinea preparado de anticorpo linhagem celular uso de fator v subunidades ou fragmentos do mesmo tendo atividade anticoagulante na forma de cofator par apc prepraro de plasma embalado plasma deficiente em atividade anticoagulante de fator v como cofator para apc uso do preparado de anticorpo preparado de proteina s preparado de
DE69411898T DE69411898T3 (de) 1993-01-29 1994-01-28 Neue antikoagulant-cofaktor aktivität
CZ951849A CZ184995A3 (en) 1993-01-29 1994-01-28 Novel anticoagulative cofactor activity
US08/500,917 US7169572B1 (en) 1993-01-29 1994-01-28 Assays for determining anticoagulant cofactor activity
EP94905908A EP0690991B2 (en) 1993-01-29 1994-01-28 Novel anticoagulant cofactor activity
PCT/SE1994/000070 WO1994017415A1 (en) 1993-01-29 1994-01-28 Novel anticoagulant cofactor activity
ES94905908T ES2119165T5 (es) 1993-01-29 1994-01-28 Nueva actividad de cofactor anticoagulante.
PL94310050A PL181102B1 (pl) 1993-01-29 1994-01-28 Sposób oznaczania w próbce funkcjonalnej aktywności wybranego składnika koagulacji krwi
CA002154080A CA2154080C (en) 1993-01-29 1994-01-28 Novel anticoagulant cofactor activity
NZ261190A NZ261190A (en) 1993-01-29 1994-01-28 Assaying for functional activity of a blood coagulation component involved in the protein c anticoagulant system (protein c, activated protein c, protein s or anticoagulant factor v)
PL34254994A PL181638B1 (pl) 1993-01-29 1994-01-28 Sposób oznaczania sklonnosci do rozwoju zakrzepicy PL
DK94905908T DK0690991T4 (da) 1993-01-29 1994-01-28 Ny antikoagulant-cofaktor-aktivitet
AT94905908T ATE168781T1 (de) 1993-01-29 1994-01-28 Neue antikoagulant-cofaktor aktivität
FI953565A FI953565A0 (sv) 1993-01-29 1995-07-26 Ny antikoagulantkofaktoraktivitet
GR980401874T GR3027697T3 (en) 1993-01-29 1998-08-20 Novel anticoagulant cofactor activity
US11/560,502 US20070212743A1 (en) 1993-01-29 2006-11-16 Assays for Determining Anticoagulant Cofactor Activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9300300A SE9300300D0 (sv) 1993-01-29 1993-01-29 A novel anticoagulant entity, antibodies reacting specifically with the entity, and diagnostic and therapeutic used of the entity

Publications (1)

Publication Number Publication Date
SE9300300D0 true SE9300300D0 (sv) 1993-01-29

Family

ID=20388725

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9300300A SE9300300D0 (sv) 1993-01-29 1993-01-29 A novel anticoagulant entity, antibodies reacting specifically with the entity, and diagnostic and therapeutic used of the entity

Country Status (2)

Country Link
PL (1) PL181638B1 (sv)
SE (1) SE9300300D0 (sv)

Also Published As

Publication number Publication date
PL181638B1 (pl) 2001-08-31

Similar Documents

Publication Publication Date Title
Bajaj et al. Simultaneous purification of bovine prothrombin and factor X: Activation of prothrombin by trypsin-activated factor X
Brunelle et al. Missing contact probing of DNA-protein interactions.
Solomon et al. Light chain-associated amyloid deposits comprised of a novel κ constant domain
Azen Genetic protein polymrophisms in human saliva: An interpretive review
FI954855A (sv) Förfarande för sållning av närvaro av en genetisk defekt associerad med trombos och/eller svag antikoagulantrespons på aktiverat protein C
ATE90792T1 (de) Diagnostische verfahren zum nachweis von lymphomen bei menschen.
ATE184052T1 (de) Gdf-1 und uog1 proteine
O'Sullivan et al. Identification of salivary basic proline-rich proteins as receptors for Candida albicans adhesion
DE59610519D1 (de) Cytoplasmatische Expression von Antikörpern, Antikörperfragmenten und Antikörperfragment-Fusionsmolekülen in E. coli
DE69129034T2 (de) Molekulare klone von hiv-1 und deren verwendung
Francus et al. An IgG2a-producing variant of an IgG2b-producing mouse myeloma cell line. Structural studies on the Fc region of parent and variant heavy chains
DE69117123T2 (de) Menschliches MK Gen und Protein-Sequenz
DE69840895D1 (de) Monospezifische antikörper gegen fibrinogen und fibrinopeptide b
Dardik et al. The structure of endothelial cell thrombospondin: Characterization of the heparin‐binding domains
SE9300300D0 (sv) A novel anticoagulant entity, antibodies reacting specifically with the entity, and diagnostic and therapeutic used of the entity
BR9713450A (pt) Quimiocinas de mamìfero
Stephenson et al. Typing of Aeromonas species by polyacrylamide-gel electrophoresis of radiolabelled cell proteins
Kaplan Proteins secreted by platelets: significance in detecting thrombosis
EP0292663A1 (en) A method for producing vitronectin
ATE346919T1 (de) Nebenhoden-spezifisches rezeptorprotein und dessen verwendung
Azen et al. Alleles at the PRB3 locus coding for a disulfide-bonded human salivary proline-rich glycoprotein (Gl 8) and a null in an Ashkenazi Jew.
HUP9801330A2 (hu) Új PKA-kötő fehérjék és alkalmazásuk
ATE548468T1 (de) Für bakterielle antigene spezifische nukleinsäuremoleküle und ihre verwendung
BR9815519A (pt) Fragmento de ácido nucleico isolado, gene quimérico, célula hospedeira transformada, método de alteração do nìvel de expressão de uma glicogenina vegetal, método de obtenção de um fragmento de ácido nucleico isolado e produto
FI885025A (fi) Koagulationshaemmande protein pp4-x, dess framstaellning och anvaendning.